Stabilin-1 expression in tumor associated macrophages

Brain Research

Volumn 1481, Issue , 2012, Pages 71-78

  David, Clément ^a   Nance, J Philip ^a   Hubbard, Jacqueline ^a   Hsu, Mike ^a   Binder, Devin ^a   Wilson, Emma H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alternatively activated macrophage; Glioblastoma; Glioma; Macrophage; Osteonectin; SPARC; Stabilin 1; Tumor associated macrophage

Indexed keywords

CYSTEINE; RECEPTOR PROTEIN; SMALL INTERFERING RNA; STABILIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GLIOMA; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BINDING; PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; UPREGULATION;

ANIMALS; ANTIGENS, CD40; BRAIN NEOPLASMS; CELL ADHESION MOLECULES, NEURONAL; CELL LINE, TUMOR; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLYCOPROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; RNA, SMALL INTERFERING; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84867098957     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.08.048     Document Type: Article

References (30)

1. L. Bingle, N.J. Brown, and C.E. Lewis The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies J. Pathol. 196 2002 254 265
2. P. Bornstein, and E.H. Sage Matricellular proteins: extracellular modulators of cell function Curr. Opin. Cell Biol. 14 2002 608 616
3. Brekken, R.A., Sage, E.H., 2001. SPARC, a matricellular protein: at the crossroads of cell-matrix communication: [Matrix Biology (2000) 569-580], Matrix Biology, Volume 19, Issue 8, January 2001, Pages 815-827, ISSN 0945-053X, 10.1016/S0945-053X(00)00133-5
4. P.E. Framson, and E.H. Sage SPARC and tumor growth: where the seed meets the soil? J. Cell. Biochem. 92 2004 679 690
5. W.A Golembieski, S. Ge, K. Nelson, T. Mikkelsen, and S. Rempel Increased SPARC expression promotes U87 glioblastoma invasion in vitro Int. J. Dev. Neurosci. 17 1999 463 472
6. W.A. Golembieski HSP27 mediates SPARC-induced changes in glioma morphology, migration, and invasion Glia 56 2008 1061 1075
7. S. Gordon, and F.O. Martinez Alternative activation of macrophages: mechanism and functions Immunity 32 2010 593 604
8. L.C. Huysentruyt, Z. Akgoc, and T.N. Seyfried Hypothesis: are neoplastic macrophages/microglia present in glioblastoma multiforme? ASN Neuro 3 2011 183 193
9. J. Kzhyshkowska Stabilin-1, a homeostatic scavenger receptor with multiple functions J. Cell. Mol. Med. 10 2006
10. J. Kzhyshkowska Stabilin-1 localizes to endosomes and the trans-golgi network in human macrophages and interacts with GGA adaptors J. Leukoc. Biol. 76 2004 1151 1161
11. J. Kzhyshkowska Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC J. Immunol. (Baltimore, Md.?: 1950) 176 2006 5825 5832
12. Y. Luo Targeting tumor-associated macrophages as a novel strategy against breast cancer J. Clin. Invest. 116 2006 2132 2141
13. A. Mantovani, G. Germano, F. Marchesi, M. Locatelli, and S.K. Biswas Cancer-promoting tumor-associated macrophages: new vistas and open questions Eur. J. Immunol. 41 2011 2522 2525
14. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol. 23 2002 549 555
15. D.M. Mosser, and J.P. Edwards Exploring the full spectrum of macrophage activation Genetics 8 2008 958 969
16. S. Palani Stabilin-1/CLEVER-1, a type 2 macrophage marker, is an adhesion and scavenging molecule on human placental macrophages Eur. J. Immunol. 41 2011 2052 2063
17. S.-Y. Park Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages J. Cell Sci. 122 2009 3365 3373
18. J.N. Rich Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model J. Biol. Chem. 278 2003 15951 15957
19. B. Ruffell, N.I. Affara, and L.M. Coussens Differential macrophage programming in the tumor microenvironment Trends Immunol. 33 2012 119 126
20. J. Schittenhelm Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas Neuropathol. Appl. Neurobiol. 32 2006 525 531
21. C. Schultz, N. Lemke, S. Ge, W.A. Golembieski, and S.A. Rempel Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo 1 Animals 62 2002 6270 6277
22. T. Seno Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas Int. J. Oncol. 34 2009 707 715 10.3892/ijo
23. T.N. Seyfried Perspectives on brain tumor formation involving macrophages, glia, and neural stem Perspect. Biol. Med. 44 2001 263 282
24. Q. Shi Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases Oncogene 26 2007 4084 4094
25. G. Solinas, G. Germano, A. Mantovani, and P. Allavena Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation J. Leukoc. Biol. 86 2009 1065 1073
26. M.E. Sughrue Immunological considerations of modern animal models of malignant primary brain tumors J. Transl. Med. 7 2009 84
27. E.A. Vasievich, and L. Huang The suppressive tumor microenvironment: a challenge in cancer immunotherapy Mol. Pharm. 8 2011 635 641
28. G. Workman, and E.H. Sage Identification of a sequence in the matricellular protein SPARC that interacts with the scavenger receptor stabilin-1 J. Cell. Biochem. 112 2011 1003 1008
29. X. Yuan Isolation of cancer stem cells from adult glioblastoma multiforme Oncogene 23 2004 9392 9400
30. B. Zhang M2-polarized tumor-associated macrophages are associated with poor prognoses resulting from accelerated lymphangiogenesis in lung adenocarcinoma Clinics 66 2011 1879 1886